TB Guidline Observation and Adherence in Low Income Countries (TB GOAL)
低收入国家结核病指导方针的观察和遵守(结核病目标)
基本信息
- 批准号:8286148
- 负责人:
- 金额:$ 20.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-07-01 至 2014-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdherenceAfrica South of the SaharaAttitudeBehaviorCaringCategoriesCause of DeathCharacteristicsCollectionCommunicable DiseasesCountryDataData AnalysesDeltastabDetectionDevelopmentDiagnosisDiagnostic testsElementsEnabling FactorsEnsureEnvironmentEvaluationFeedbackFundingFutureGoalsGovernmentGuidelinesHealthHealth PersonnelHealth PromotionHealth systemIncidenceIndividualInternationalInterventionKnowledgeLaboratory TechniciansLeadLow incomeMeasuresMicroscopyMissionModelingMorbidity - disease rateNursesPatientsPerformancePilot ProjectsPlanning TheoryPositive Test ResultPredisposing FactorProviderReinforcing FactorReportingResearchResearch SubjectsResourcesRiskSeriesSiteSolidSpecimenSputumStudy modelsSystemTestingTimeTrainingTuberculosisUgandaUnited States National Institutes of HealthWorkWorld Health Organizationbasebehavior changecost effectivedesigneffective interventionevidence based guidelinesimprovedmortalitymulti-component interventionnovel diagnosticspreventrandomized trialsurveillance networktrendtuberculosis treatmentuptake
项目摘要
DESCRIPTION (provided by applicant): The World Health Organization estimates that tuberculosis (TB) elimination can be achieved by 2050 if 70% of estimated sputum smear-positive TB cases are identified and 85% are treated successfully.1-3 Unfortunately, smear-positive TB case detection rates are far below the 70% target in most high burden countries.1 To improve case detection and management, the Tuberculosis Coalition for Technical Assistance developed evidence-based guidelines called the International Standards for TB Care (ISTC).6 Adherence to ISTC-recommended practices for TB suspect evaluation is poor in low-income countries.5,7 Thus, improving ISTC implementation offers a tremendous opportunity to reduce the global burden of TB. Our long-term objective is to determine whether a multi-faceted intervention to improve ISTC implementation reduces TB-related morbidity and mortality in low-income countries. The proposed multi-faceted intervention addresses three categories of factors that are critical for changing behavior: (1) predisposing factors - knowledge or attitudes that either support or inhibit the desired behavior; (2) enabling factors - characteristics of an individual or environment that facilitate the desired behavior; and (3) reinforcing factors -anticipated consequences of following the desired behavior.9,10 Thus, the multi-faceted intervention includes (1) ISTC training modules to improve provider knowledge and attitudes toward ISTC; (2) single-specimen microcopy (a more efficient smear microscopy strategy) to enable ISTC adherence; and (3) a performance feedback system to reinforce ISTC adherence. The pilot studies proposed in this R21 application are designed to evaluate the feasibility and impact of each of these intervention components. The data will inform a future R01 application to assess whether a multi-faceted intervention to improve ISTC adherence actually increases TB case detection. For the pilot studies, our hypothesis is that each component will improve provider adherence to ISTC-recommended TB suspect evaluation practices. The pilot studies will take place within the Uganda Infectious Disease Surveillance Network (UIDSN), which collects data on TB care at 6 government health centers (>100,000 annual patient encounters) that are typical of those seen throughout sub-Saharan Africa. The research subjects are the approximately 50 providers (3- 4 clinicians, 1-2 laboratory technicians, and 2-3 nurses per health center) working at the 6 UIDSN health centers. To test our hypothesis, each intervention component will be introduced at the 6 UIDSN health centers in a sequential fashion. Data from approximately 2500 TB suspects will be used to objectively measure provider adherence to ISTC before and after introduction of each intervention component. If successful, the proposed studies could help reverse the current trend of rising global TB incidence and are consistent with NIAID's mission to prevent infectious diseases that threaten millions of lives. In addition, this research will lead to a better understanding of the factors and types of interventions associated with successful evidence-based guideline implementation and strengthened health systems in resource-limited settings.
描述(由申请人提供):世界卫生组织估计,如果确定了70%的估计痰液涂片阳性的结核病病例,可以在2050年实现结核病(TB)消除,并成功治疗了85%,而1-3不幸的是,涂片阳性的TB案例检测率在大多数高率的情况下都远低于70%的助手。基于证据的指南称为国际结核病护理标准(ISTC)。6在低收入国家中,遵守ISTC强制性的TB嫌疑犯评估的做法很差。5,7因此,改善ISTC实施提供了巨大的机会,可以减轻全球TB负担。 我们的长期目标是确定以改善ISTC实施的多方面干预措施是否会降低低收入国家中与TB相关的发病率和死亡率。提出的多面干预措施解决了对改变行为至关重要的三类因素:(1)诱发因素 - 知识或支持或抑制所需行为的知识或态度; (2)启用因素 - 促进所需行为的个体或环境的特征; (3)加强因素遵循所需行为的后果。9,10因此,多方面的干预措施包括(1)ISTC培训模块,以提高提供者知识和对ISTC的态度; (2)单特异性微拷贝(一种更有效的涂片显微镜策略),以实现ISTC依从性; (3)绩效反馈系统以增强ISTC依从性。 R21应用程序中提出的试点研究旨在评估这些干预组件中每一个的可行性和影响。这些数据将为未来的R01应用程序提供信息,以评估多方面的干预措施是否提高ISTC依从性实际上会增加TB病例检测。 对于试点研究,我们的假设是,每个组件都将提高提供者遵守ISTC征求的TB可疑评估实践。试点研究将在乌干达传染病监视网络(UIDSN)中进行,该网络收集了6个政府卫生中心(> 100,000例年度患者遇到的TB护理数据,这些数据是整个撒哈拉以南非洲地区的典型患者。研究对象是在UIDSN健康中心工作的大约50个提供者(3-4名临床医生,1-2个实验室技术人员和2-3名护士)。 为了检验我们的假设,每个干预组件将以连续的方式在6个UIDSN健康中心引入。来自大约2500个TB嫌疑人的数据将用于在引入每个干预组件之前和之后客观地测量提供商遵守ISTC。如果成功的话,拟议的研究可能有助于扭转全球结核病发生率上升的当前趋势,并与Niaid的使命一致,那就是防止威胁着数百万生命的传染病。此外,这项研究将更好地理解与成功的基于证据的指南实施相关的干预措施的因素和类型,并在资源有限的环境中加强了卫生系统。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Pathways and costs of care for patients with tuberculosis symptoms in rural Uganda.
- DOI:10.5588/ijtld.14.0166
- 发表时间:2015-08
- 期刊:
- 影响因子:0
- 作者:Shete PB;Haguma P;Miller CR;Ochom E;Ayakaka I;Davis JL;Dowdy DW;Hopewell P;Katamba A;Cattamanchi A
- 通讯作者:Cattamanchi A
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Adithya Cattamanchi其他文献
Adithya Cattamanchi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Adithya Cattamanchi', 18)}}的其他基金
PROgression of Tuberculosis infECTion in young children living with and without HIV: the PROTECT study
感染和未感染艾滋病毒的幼儿结核感染的进展:PROTECT 研究
- 批准号:
10641389 - 财政年份:2023
- 资助金额:
$ 20.14万 - 项目类别:
Partnerships for Research in Implementation Science for Equity in Heart and Lung diseases training program (PRISE-HL T32)
心肺疾病公平实施科学研究伙伴关系培训计划 (PRISE-HL T32)
- 批准号:
10553831 - 财政年份:2023
- 资助金额:
$ 20.14万 - 项目类别:
Rapid Research for Diagnostics Development in TB Network (R2D2 TB Network)
结核病网络诊断开发快速研究(R2D2 结核病网络)
- 批准号:
10416088 - 财政年份:2020
- 资助金额:
$ 20.14万 - 项目类别:
Rapid Research for Diagnostics Development in TB Network (R2D2 TB Network)
结核病网络诊断开发快速研究(R2D2 结核病网络)
- 批准号:
9981550 - 财政年份:2020
- 资助金额:
$ 20.14万 - 项目类别:
Childhood ‘Omics’ and Mycobacterium tuberculosis-derived BiOsignatures (COMBO) for TB diagnosis in high HIV prevalence settings
儿童组学和结核分枝杆菌衍生生物特征 (COMBO) 用于艾滋病毒高流行地区的结核病诊断
- 批准号:
10375468 - 财政年份:2020
- 资助金额:
$ 20.14万 - 项目类别:
Rapid Research for Diagnostics Development in TB Network (R2D2 TB Network)
结核病网络诊断开发快速研究(R2D2 结核病网络)
- 批准号:
10631188 - 财政年份:2020
- 资助金额:
$ 20.14万 - 项目类别:
Rapid Research for Diagnostics Development in TB Network (R2D2 TB Network)
结核病网络诊断开发快速研究(R2D2 结核病网络)
- 批准号:
10244868 - 财政年份:2020
- 资助金额:
$ 20.14万 - 项目类别:
Childhood ‘Omics’ and Mycobacterium tuberculosis-derived BiOsignatures (COMBO) for TB diagnosis in high HIV prevalence settings
儿童组学和结核分枝杆菌衍生生物特征 (COMBO) 用于艾滋病毒高流行地区的结核病诊断
- 批准号:
10677740 - 财政年份:2020
- 资助金额:
$ 20.14万 - 项目类别:
Childhood ‘Omics’ and Mycobacterium tuberculosis-derived BiOsignatures (COMBO) for TB diagnosis in high HIV prevalence settings
儿童组学和结核分枝杆菌衍生生物特征 (COMBO) 用于艾滋病毒高流行地区的结核病诊断
- 批准号:
10811547 - 财政年份:2020
- 资助金额:
$ 20.14万 - 项目类别:
Options for Delivery of Short-Course Tuberculosis Preventive Therapy: The 3HP Options Trial
提供短期结核病预防治疗的选项:3HP 选项试验
- 批准号:
10212447 - 财政年份:2018
- 资助金额:
$ 20.14万 - 项目类别:
相似国自然基金
坚持还是转型?反馈驱动的创业者机会信念认知更新及响应决策机理
- 批准号:
- 批准年份:2022
- 资助金额:45 万元
- 项目类别:面上项目
坚持还是转型?反馈驱动的创业者机会信念认知更新及响应决策机理
- 批准号:72272131
- 批准年份:2022
- 资助金额:45.00 万元
- 项目类别:面上项目
不确定性下创业团队能量和抗逆力对创业坚持的权变影响研究
- 批准号:72162025
- 批准年份:2021
- 资助金额:29 万元
- 项目类别:地区科学基金项目
创造性思维中灵活性和坚持性动态交互的神经基础
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
创造性思维中灵活性和坚持性动态交互的神经基础
- 批准号:32100850
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Understand and mitigating the influence of extreme weather events on HIV outcomes: A global investigation
了解并减轻极端天气事件对艾滋病毒感染结果的影响:一项全球调查
- 批准号:
10762607 - 财政年份:2023
- 资助金额:
$ 20.14万 - 项目类别:
Adapting and Piloting an Evidence-based Intervention to Improve Hypertension Care among Tanzanians Living with HIV
调整和试点循证干预措施以改善坦桑尼亚艾滋病毒感染者的高血压护理
- 批准号:
10750666 - 财政年份:2023
- 资助金额:
$ 20.14万 - 项目类别:
Designing an Ethnodrama Intervention Addressing PrEP Stigma Toward Young Women
设计民族戏剧干预措施,解决针对年轻女性的 PrEP 耻辱
- 批准号:
10755777 - 财政年份:2023
- 资助金额:
$ 20.14万 - 项目类别:
Bridges2Scale: Testing implementation strategies for an intervention among young people affected by AIDS
Bridges2Scale:测试对受艾滋病影响的年轻人进行干预的实施策略
- 批准号:
10713990 - 财政年份:2023
- 资助金额:
$ 20.14万 - 项目类别:
Sustained Release of Potent Antiviral Prodrugs for HIV Prevention
持续释放有效的抗病毒前药以预防艾滋病毒
- 批准号:
10617540 - 财政年份:2023
- 资助金额:
$ 20.14万 - 项目类别: